The 21st Century Cures Act [aka: the Cures Act], was passed by the Senate [95-4] and the House of Representatives [392-26] and signed into law by the President in December 2016. In addition to increasing funding for medical research, the act creates an accelerated pathway for the development of regenerative treatments. The Act provides new guidelines to enable the FDA to fast track clinical trials and streamline the approval process for regenerative therapies.
